B
Bexorg
Transforming brain research with molecular platforms to combat neurological diseases
About Bexorg
Bexorg is at the forefront of neuroscience, leveraging proprietary technology to transform entire brains into molecular and interventional platforms. This groundbreaking approach allows for unprecedented exploration of the brain, aiming to eliminate neurological diseases. Bexorg's platform is capable of manipulating and recording the cellular activity of fully mature, intact, and isolated brains for extended periods, surpassing the limitations of traditional cell cultures or organoids. The company operates in the medical research sector, focusing on advancing brain disease therapies that were previously at an impasse. Bexorg's business model involves partnering with research institutions and healthcare organizations to develop and implement these transformative therapies. Revenue is generated through collaborations and the application of their proprietary systems in research and therapeutic development. Keywords: neuroscience, brain research, molecular platforms, neurological diseases, proprietary technology, cellular activity, brain perfusion, medical research, therapeutic development, healthcare partnerships.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2021
- Headquarters
- New Haven, United States
- Employees
- 48
- Open positions
- 3
- Dealroom signal
- 91.1/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, BioTechnology, Medical Devices
- Sector
- Biotech & Life Sciences, Biotechnology, Neurology, Spinout, Biotech and Pharma, Brain Computer Interfaces, AI Drug Discovery, Techbio Drug Discovery
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Oct 2025 | $23M | $92M | Amplify Partners · Starbloom Capital · E1 ventures · Engine Ventures | ↗ |
| SEED✓Equity / VC | Oct 2024 | $20M | $80M | Undisclosed | — |
Growth signals
Latest recorded traffic for Bexorg is 7.8K monthly website visits, up 239.1% over the last three months. Bexorg's team grew 71.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A5 investors entered at this stage
Engine Ventures
Amplify Partners
Starbloom Capital
E1 ventures
Connecticut Innovations
Other known investors2 additional known investors
University of California, Los Angeles
Yale Ventures
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Bexorg on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Bexorg’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.